Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D07XC04	AZONIT - D	G	Diflucortolone valerate - 1mg/g, Isoconazole nitrate - 10mg/g		Cream	225,766 L.L
N02BE51	ADOL EXTRA	G	Paracetamol - 500mg, Caffeine - 65mg		Caplet	122,290 L.L
N02BE51	ALGIN ADULTS	G	Paracetamol - 400mg, Caffeine - 50mg		Suppository	195,817 L.L
S01EE01	API-LOPROST	G	Latanoprost - 0.005%	0.005%	Drops	447,500 L.L
R01AD09	AVOCOM	G	Mometasone furoate - 0.05%	0.05%	Spray	419,279 L.L
D10AD01	A-RET	G	Tretinoin - 0.05%	0.05%	Cream	335,961 L.L
D10AD01	AVOTIN-A	G	Tretinoin - 0.05%	0.05%	Cream	440,780 L.L
A03BA01	ATROPINE SULFATE RENAUDIN	G	Atropine sulfate - 1mg/ml	0.1%	Injectable solution	397,777 L.L
R01AC03	ALLERGODIL NASAL	B	Azelastine HCl - 0.14mg/dose	0.14mg/dose	Spray, solution	657,139 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	1,001,163 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	1,001,163 L.L
S01EA05	ALPHANOVA	G	Brimonidine tartrate - 0.15%	0.15%	Drops solution	599,354 L.L
A03BA01	ATROPINE SULFATEAGUETTANT	G	Atropine - 0.1mg/ml	0.1mg/ml	Injectable solution	7,805,376 L.L
C01CA24	ADRENALINE AGUETTANT	G	Adrenaline - 0.1mg/ml	0.1mg/ml	Injectable solution	13,990,891 L.L
N05BA12	ALPRAZOLAM BIOGARAN	G	Alprazolam - 0.25mg	0.25mg	Tablet, scored	115,570 L.L
N02CX01	APIZINE	G	Pizotifen - 0.25mg/5ml	0.25mg/5ml	Syrup	505,541 L.L
A04AA05	ALOXI	B	Palonosetron HCl - 0.25mg/5ml	0.25mg/5ml	Injectable solution	3,656,595 L.L
A03BA01	ATROPINE I.V. 0.25 MG.	G	Atropine - 0.25mg/ml	0.25mg/ml	Injectable solution	2,412,129 L.L
B01AC17	AGGRASTAT	B	Tirofiban hydrochloride monohydrate - 0.25mg/ml	0.25mg/ml	Injectable concentrated solution	18,280,324 L.L
N02BA01	ASPIRINE	B	Acetylsalicylic acid - 300mg	0.3g	Tablet	80,631 L.L
S01HA02	ANESTOCIL	B	Oxybuprocaine HCl (Benoxinate HCl) - 0.4%	0.4%	Drops solution	442,124 L.L
G04CA02	APO-TAMSULOSIN CR	G	Tamsulosin HCl - 0.4mg	0.4mg	Tablet	607,417 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 0.5%	0.5%	Injectable solution	1,441,943 L.L
S01AE07	AROX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	423,310 L.L
J01DH02	AROPEM	G	Meropenem (trihydrate) - 0.5g	0.5g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	19,022,727 L.L
G04CB02	AVODART	B	Dutasteride - 0.5mg	0.5mg	Capsule	2,568,489 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 0.5mg	0.5mg	Capsule, prolonged release	13,297,758 L.L